Bain Capital Life Sciences Investors, LLC SVRA — SAVARA INC

Ownership history in Bain Capital Life Sciences Investors, LLC  ·  27 quarters on record

AI Ownership Summary

Bain Capital Life Sciences Investors, LLC reported SAVARA INC (SVRA) in 27 quarterly 13F filings from 2024 Q1 through 2026 Q2. Peak portfolio weight reached 8.67% in 2026 Q1. The latest visible filing shows SVRA at 6.45% of the fund.

This page tracks quarterly shares, estimated market value, portfolio weight, filing dates, and disclosure-aligned stock prices directly from SEC EDGAR 13F filings. Older history is available after unlock; the visible window still shows the most recent pattern.

What this SVRA ownership page tells you

This page is designed to answer the real investor question behind a 13F filing: how meaningful was Bain Capital Life Sciences Investors, LLC's position in SAVARA INC, and how did that conviction change over time? You can read the holding window, peak weight, latest reported size, disclosure timing, and quarter-by-quarter changes without piecing the story together from raw SEC rows.

Freshest filing
Latest Reported Filing
2026 Q2

SVRA was reported at 6.45% of portfolio in the most recent visible filing.

High-water mark
Peak Conviction
8.67% in 2026 Q1

Peak weight helps separate a token disclosure from a real conviction holding the fund genuinely cared about.

Time in book
Holding Window
2024 Q1 to 2026 Q2

Longer holding windows often tell a very different story from short-lived tactical trades or one-quarter experiments.

Decision context
Why It Matters
Position size beats headlines

Knowing that a fund owned a stock is useful. Knowing whether it was a 0.20% placeholder or a true high-conviction position is where the signal actually starts.

SVRA stock page Bain Capital Life Sciences Investors, LLC fund profile Bain Capital Life Sciences Investors, LLC full holdings
How Bain Capital Life Sciences Investors, LLC held SVRA — position size vs. price
% of Fund (quarterly)    SVRA price (quarter-end, indexed to 100)    SPY (indexed to 100)    QQQ (indexed to 100)
📋 Quarterly Holdings History 10 quarters  ▾
Quarter Action Sold % After 3M Timing Shares Change Chg % % of Fund Mkt Value Filed Price (Filed)
2026 Q2 UNCHANGED — — — 17,600,621 — 0% 6.45% $108.4M 2026-08-14 $5.38
2026 Q1 UNCHANGED — — — 17,600,621 — 0% 8.67% $96.1M 2026-05-15 $5.03
2025 Q4 UNCHANGED — — — 17,600,621 — 0% 8.13% $106.1M 2026-02-17 $5.73
2025 Q3 UNCHANGED — — — 17,600,621 — 0% 4.17% $62.8M 2025-11-14 $4.30
2025 Q2 UNCHANGED — — — 17,600,621 — 0% 5.02% $40.13B 2025-08-14 $3.01
2025 Q1 ADDED — — — 17,600,621 +3,035,164 +20.8% 7.21% $48.75B 2025-05-15 $3.11
2024 Q4 UNCHANGED — — — 14,565,457 — 0% 5.26% $44.72B 2025-02-14 $2.82
2024 Q3 UNCHANGED — — — 14,565,457 — 0% 6.43% $61.8M 2024-11-14 $3.19
2024 Q2 UNCHANGED — — — 14,565,457 — 0% 6.44% $58.7M 2024-08-12 $4.10
2024 Q1 ADDED — — — 14,565,457 +332,706 +2.3% 5.83% $72.5M 2024-05-15 $4.83
17 older quarters hidden  —  Sign in free or upgrade to Premium to see full history

🏢 Other funds also holding SVRA

As of 2026 Q2 — sorted by position size

NEA Management Company, LLC 3Y 7Y 9.49% Rosalind Advisors, Inc. 7.27% Spruce Street Capital LP 4.17% SUPERSTRING CAPITAL MANAGEMENT LP 3.8% Venrock Adviser, LLC 3Y 2.75% KVP Capital Advisors, LP 2.74% TCG Crossover Management, LLC 3Y 1.83% Nantahala Capital Management, LLC 3Y 7Y 1.43% Frazier Life Sciences Management, L.P. 3Y 1.3% NAN FUNG TRINITY (HK) Ltd 3Y 1.12%

FAQ About Bain Capital Life Sciences Investors, LLC and SVRA

These are the practical questions this page is built to answer before you even open the full history table.

How long has Bain Capital Life Sciences Investors, LLC reported owning SVRA?

Bain Capital Life Sciences Investors, LLC reported SVRA across 10 quarterly 13F filings, from 2024 Q1 through 2026 Q2.

What was the largest reported SVRA position in Bain Capital Life Sciences Investors, LLC's portfolio?

The largest reported portfolio weight for SVRA was 8.67% in 2026 Q1.

What is the latest reported SVRA position on this page?

The most recent filing on this page is 2026 Q2, when Bain Capital Life Sciences Investors, LLC reported 17,600,621 shares, equal to 6.45% of portfolio, with an estimated market value of $108.4M.

What does the chart on this SVRA ownership page compare?

The chart compares Bain Capital Life Sciences Investors, LLC's quarterly SVRA portfolio weight with the stock's indexed share price, so you can see whether the fund was building, trimming, or holding the position as price moved.

How well did Bain Capital Life Sciences Investors, LLC time their SVRA position?

Based on 13F filing dates vs. subsequent SVRA price moves, Bain Capital Life Sciences Investors, LLC correctly timed 1 out of 5 reported position changes (20%). The annualised alpha on SVRA relative to SPY over the holding period was +15.7%.

← Back to Bain Capital Life Sciences Investors, LLC Holdings